Compound Summary
Compound Information
sulpiride
Compound Name: | sulpiride |
Compound CID: | 5355 |
Synonyms: | sulpiride 15676-16-1 Sulpyrid Sulpirid Aiglonyl More... |
Iupac Name: | N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide |
InChI: | InChI=1S/C15H23N3O4S/c1-3-18-8-4-5-11(18)10-17-15(19)13-9-12(23(16,20)21)6-7-14(13)22-2/h6-7,9,11H,3-5,8,10H2,1-2H3,(H,17,19)(H2,16,20,21) |
InChIKey: | BGRJTUBHPOOWDU-UHFFFAOYSA-N |
Canonical Smiles: | CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC |
Isomeric Smiles: | CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC |
Molecular Weight: | 341.4 |
Molecular Formula: | C15H23N3O4S |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
sulpiride
Molecular Weight: | 341.4 |
Molecular Formula: | C15H23N3O4S |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 6 |
Rotatable Bond Count: | 6 |
Heavy Atom Count: | 23 |
Complexity: | 505 |
Synonyms
sulpiride
| sulpiride | sulpiride |
|---|---|
sulpiride |
15676-16-1 |
Sulpyrid |
Sulpirid |
Aiglonyl |
Dolmatil |
Dogmatil |
(+/-)-Sulpiride |
Dobren |
Guastil |
(RS)-(+/-)-sulpiride |
Dogmatyl |
Mirbanil |
Misulvan |
Sursumid |
Abilit |
Eglonyl |
Meresa |
Miradol |
Neogama |
Omperan |
Splotin |
Coolspan |
Pyrkappl |
Sernevin |
N-(1-ethylpyrrolidin-2-yl)methyl-2-methoxy-5-sulfamoylbenzamide |
Sulpiridum INN-Latin |
Sulpirida INN-Spanish |
Sulpirida |
Sulpiridum |
dl-sulpiride |
RD 1403 |
N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide |
N-((1-Ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoylbenzamide |
R.D. 1403 |
5-(Aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxybenzamide |
Benzamide, 5-(aminosulfonyl)-N-(1-ethyl-2-pyrrolidinyl)methyl-2-methoxy- |
CHEMBL26 |
Psicocen |
C15H23N3O4S |
Calmoflorine |
Championyl |
Lisopiride |
Stamonevrol |
Alimoral |
Darleton |
Desmenat |
Dresent |
Eglonil |
Equilid |
Eusulpid |
Fardalan |
Fidelan |
Isnamide |
Kylistro |
Mariastel |
Norestran |
Nufarol |
Ozoderpin |
Restful |
Sulpitil |
Suprium |
Valirem |
Zemorcon |
CHEBI:32168 |
Enimon |
Normum |
o-Anisamide, N-((1-ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl- |
Omiryl |
Levosulpiridum INN-Latin |
N-(1-ethylpyrrolidin-2-yl)methyl-2-methoxy-5-sulfamoyl-benzamide |
Levosulpirida INN-Spanish |
Benzamide, 5-(aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy- |
MFCD00055061 |
Synedil |
Sulpiride-R |
Pyrikappl |
Sulpor |
n-((1-ethylpyrrolidin-2-yl)methyl)-2-methoxy-5-sulfamoylbenzamide |
(+)-N-(1-Ethylpyrrolidin-2-yl)methyl-2-methoxy-5-sulfamoyl-benzamide |
5-(Aminosulfonyl)-N-(1-ethyl-2-pyrrolidinyl)methyl-2-methoxybenzamide |
SMR000038923 |
CCRIS 4248 |
SULPIRIDE,(+) |
Sulpiride USAN:INN:BAN:JAN |
SR-01000075402 |
EINECS 239-753-7 |
BRN 0494008 |
L-Sulpiride |
(S)-N-((1-ethylpyrrolidin-2-yl)methyl)-2-methoxy-5-sulfamoylbenzamide |
(y)-Sulpiride |
N05AL01 |
Sulpiride, SLP |
(plusmn)-sulpiride |
Dogmatyl (TN) |
Magnetic resonance imaging sulpiride |
(?)-Sulpiride |
Prestwick_431 |
(+-)-sulpiride |
CAS-15676-16-1 |
(.+/-.)-Sulpiride |
Prestwick0_000056 |
Prestwick1_000056 |
Prestwick2_000056 |
Prestwick3_000056 |
SULPIRIDE,(-) |
Biomol-NT_000037 |
Biomol-NT_000162 |
SCHEMBL8421 |
DSSTox_CID_22574 |
DSSTox_RID_80050 |
DSSTox_GSID_42574 |
Lopac0_001050 |
Oprea1_602476 |
BSPBio_000211 |
5-22-08-00105 (Beilstein Handbook Reference) |
MLS000069434 |
MLS001306443 |
DivK1c_000278 |
SPBio_002132 |
BPBio1_000233 |
BPBio1_000463 |
BPBio1_001255 |
CCRIS-4248 |
GTPL5501 |
Sulpiride (JP17/USAN/INN) |
DTXSID1042574 |
BDBM11638 |
HMS500N20 |
KBio1_000278 |
NINDS_000278 |
Sulpiride 1.0 mg/ml in Methanol |
HMS1568K13 |
HMS2095K13 |
HMS2231K07 |
HMS3263A22 |
HMS3266P12 |
HMS3371P16 |
HMS3372O01 |
HMS3393A08 |
HMS3411D18 |
HMS3651G12 |
HMS3675D18 |
HMS3712K13 |
HMS3885J14 |
BCP04500 |
BCP13871 |
HY-B1019 |
STR09321 |
( inverted question mark)-Sulpiride |
Tox21_302205 |
Tox21_501050 |
s4655 |
STK368596 |
5-(Aminosufonyl)-N-(1-ethyl-2-pyrrolidinyl)methyl-2-methoxybenzamide |
AKOS004912732 |
CCG-205127 |
CS-4534 |
DB00391 |
LP01050 |
MCULE-7506797476 |
NSC 757850 |
RD-1403 |
SDCCGSBI-0051020.P002 |
IDI1_000278 |
NCGC00015966-03 |
NCGC00015966-04 |
NCGC00015966-05 |
NCGC00015966-06 |
NCGC00015966-07 |
NCGC00015966-08 |
NCGC00015966-16 |
NCGC00024852-02 |
NCGC00024852-03 |
NCGC00024852-04 |
NCGC00024852-05 |
NCGC00255813-01 |
NCGC00261735-01 |
AC-12181 |
AB0105833 |
DB-046215 |
EU-0001755 |
EU-0101050 |
FT-0630504 |
FT-0652244 |
FT-0674703 |
R. D. 1403 |
D01226 |
J10067 |
S 8010 |
676S161 |
A809768 |
L000579 |
Q422418 |
SR-01000075402-2 |
SR-01000075402-3 |
SR-01000075402-6 |
BRD-A55272860-001-03-9 |
BRD-A55272860-001-04-7 |
BRD-A55272860-001-08-8 |
Z84655412 |
Sulpiride, British Pharmacopoeia (BP) Reference Standard |
1-ethyl-2-(2-methoxy-5-sulfamoylbenzamidomethyl)pyrrolidine |
Sulpiride, European Pharmacopoeia (EP) Reference Standard |
N-(1-Ethyl-pyrrolidin-2-ylmethyl)-2-methoxy-5-sulfamoyl-benzamide |
(+/-)-N-(1-Ethylpyrrolidin-2-yl)methyl-2-methoxy-5-sulfamoylbenzamide |
(+/-)-N-1-(Ethylpyrrolidin-2-ylmethyl)-2-methoxy-5-sulfamoylbenzamide |
(2R)-1-Ethyl-2-((2-methoxy-5-sulfamoylbenzamido)methyl)pyrrolidin-1-ium |
Benzamide,5-(aminosulfonyl)-N-(1-ethyl-2-pyrrolidinyl)methyl-2-methoxy- |
(+/-)-5-(Aminosulfonyl)-N-(1-ethyl-2-pyrrolidinyl)methyl-2-methoxybenzamide |
(RS)-(+/-)-5-Aminosulfonyl-N-(1-ethyl -2-pyrrolidinyl)methyl-2-methoxybenzamide |
(RS)-(+/-)-5-Aminosulfonyl-N-(1-ethyl-2-pyrrolidinyl)methyl-2-methoxybenzamide |
( inverted question mark)-5-(Aminosulfonyl)-N-(1-ethyl-2-pyrrolidinyl)methyl-2-methoxybenzamide |
Experimental Data
sulpiride
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | -3 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
sulpiride
Statistics Data
sulpiride
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -3 | 1 | 1 |
Statistics Data Visualization
sulpiride
